Loading viewer...
earnings
Format: PDF earnings
Amgen's Q2 2023 earnings presentation delivered on August 3, 2023, includes forward-looking statements on product performance, acquisitions including Horizon Therapeutics, and financial guidance. The deck covers clinical developments, commercial updates, and strategic initiatives across Amgen's biopharmaceutical portfolio. Risk factors and safe harbor disclosures detail regulatory, manufacturing, and competitive challenges affecting the company's operations.
presentation
earnings
17 Pages
Absolute Software